These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Unbiased split variable selection for random survival forests using maximally selected rank statistics. Wright MN; Dankowski T; Ziegler A Stat Med; 2017 Apr; 36(8):1272-1284. PubMed ID: 28088842 [TBL] [Abstract][Full Text] [Related]
44. Improved Kaplan-Meier Estimator in Survival Analysis Based on Partially Rank-Ordered Set Samples. Nematolahi S; Nazari S; Shayan Z; Ayatollahi SMT; Amanati A Comput Math Methods Med; 2020; 2020():7827434. PubMed ID: 32587630 [TBL] [Abstract][Full Text] [Related]
45. Crossover studies with continuous variables: power analysis. Cleophas TJ; Zwinderman AH Am J Ther; 2002; 9(1):69-73. PubMed ID: 11782821 [TBL] [Abstract][Full Text] [Related]
46. Incorporating baseline measurements into the analysis of crossover trials with time-to-event endpoints. Xu R; Mehrotra DV; Shaw PA Stat Med; 2018 Oct; 37(23):3280-3292. PubMed ID: 29888552 [TBL] [Abstract][Full Text] [Related]
47. An adaptive two-stage design with treatment selection using the conditional error function approach. Wang J Biom J; 2006 Aug; 48(4):679-89. PubMed ID: 16972720 [TBL] [Abstract][Full Text] [Related]
48. Optimizing Aggregated N-Of-1 Trial Designs for Predictive Biomarker Validation: Statistical Methods and Theoretical Findings. Hendrickson RC; Thomas RG; Schork NJ; Raskind MA Front Digit Health; 2020; 2():13. PubMed ID: 34713026 [No Abstract] [Full Text] [Related]
49. Empirical Likelihood in Nonignorable Covariate-Missing Data Problems. Xie Y; Zhang B Int J Biostat; 2017 Apr; 13(1):. PubMed ID: 28441139 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of graphical diagnostics for assessing goodness of fit of logistic regression models. Pavan Kumar VV; Duffull SB J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):205-22. PubMed ID: 21153868 [TBL] [Abstract][Full Text] [Related]
51. A New Method for Imputing Censored Values in Crossover Designs with Time-to-Event Outcomes Using Median Residual Life. Jalali M; Bagheri Z; Zare N; Ayatollahi SMT Biomed Res Int; 2020; 2020():8475154. PubMed ID: 33376742 [TBL] [Abstract][Full Text] [Related]
52. Referent selection in case-crossover analyses of acute health effects of air pollution. Levy D; Lumley T; Sheppard L; Kaufman J; Checkoway H Epidemiology; 2001 Mar; 12(2):186-92. PubMed ID: 11246579 [TBL] [Abstract][Full Text] [Related]
53. Response adaptive designs for Phase II trials with binary endpoint based on context-dependent information measures. Kasianova K; Kelbert M; Mozgunov P Comput Stat Data Anal; 2021 Jun; 158():107187. PubMed ID: 34083846 [TBL] [Abstract][Full Text] [Related]
54. Meta-analysis combining parallel and crossover trials using generalised estimating equation method. Curtin F Res Synth Methods; 2017 Sep; 8(3):312-320. PubMed ID: 28585280 [TBL] [Abstract][Full Text] [Related]
55. The construction of multi-factor crossover designs in animal husbandry studies. Bate ST; Boxall J Pharm Stat; 2008; 7(3):179-94. PubMed ID: 17559103 [TBL] [Abstract][Full Text] [Related]
56. A novel weighting method to remove bias from within-subject exposure dependency in case-crossover studies. Kubota K; Kelly TL; Sato T; Pratt N; Roughead E; Yamaguchi T BMC Med Res Methodol; 2021 Oct; 21(1):214. PubMed ID: 34657592 [TBL] [Abstract][Full Text] [Related]
57. A robust and accurate method for feature selection and prioritization from multi-class OMICs data. Fortino V; Kinaret P; Fyhrquist N; Alenius H; Greco D PLoS One; 2014; 9(9):e107801. PubMed ID: 25247789 [TBL] [Abstract][Full Text] [Related]
58. Constrained empirical-likelihood confidence regions in nonignorable covariate-missing data problems. Xie Y; Zhang B Stat Med; 2019 Feb; 38(3):452-479. PubMed ID: 30311246 [TBL] [Abstract][Full Text] [Related]
59. Parsimonious covariate selection with censored outcomes. DiRienzo AG Biometrics; 2016 Jun; 72(2):452-62. PubMed ID: 26410381 [TBL] [Abstract][Full Text] [Related]
60. Empirical evidence of bias in infertility research: overestimation of treatment effect in crossover trials using pregnancy as the outcome measure. Khan KS; Daya S; Collins JA; Walter SD Fertil Steril; 1996 May; 65(5):939-45. PubMed ID: 8612853 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]